Respiratory Syncytial Virus Polymerase Protein and Promoter Interactions

描述（由申请方提供）：呼吸道合胞病毒（RSV）是婴儿呼吸道感染的最重要原因，也是免疫功能低下患者和老年人疾病的重要原因。此外，RSV与其他高致病性病毒，如埃博拉病毒和尼帕病毒密切相关，是研究其分子生物学的良好模型。RSV具有通过病毒聚合酶转录和复制以产生mRNA和子代基因组的RNA基因组。该项目的重点是RSV聚合酶复合物与其启动子在RSV基因组中的相互作用的表征。这将通过实现三个主要目标来实现。(1)将使用表面残基修饰和UV交联技术鉴定与启动子中其结合位点相互作用的RSV聚合酶区域。将通过反向遗传学，使用允许在细胞内环境中分析RSV转录和复制的微型基因组测定，确认相互作用位点的鉴定。(2)将检查RNA复制的延伸阶段所必需的腺苷酸化起始的机制。将在RSV全长克隆中的腺苷酸化信号中进行突变，并将应用正向遗传学方法来鉴定它可能与哪种病毒蛋白以及该蛋白内的哪个区域相互作用。(3)将使用聚合酶复合物的免疫沉淀、质谱法和蛋白质印迹法鉴定与聚合酶复合物相互作用的病毒和细胞蛋白。将通过抑制它们的表达并检查微小基因组系统和RSV感染细胞中的RSV RNA合成来确定相关细胞蛋白在RSV RNA合成的不同阶段中的作用。将研究已知差异调节转录和复制的启动子突变的影响，以确定它们是否影响结合启动子的聚合酶复合物的组成。这项研究将提供有关蛋白质-RNA复合物的组成和调控的信息，该复合物在RSV增殖中起关键作用。从长远来看，这项工作将允许对这种复合物进行详细的结构分析，这可以帮助设计抑制剂来控制RSV感染，并且可以鉴定可以在病毒基因组中产生的突变以产生减毒活RSV疫苗。公共卫生相关性：呼吸道合胞病毒（RSV）是一种主要的人类病原体，导致大量儿科住院和老年人季节性疾病。该项目的目的是推进我们对病毒增殖周期中关键步骤的分子理解，长期目标是开发抗病毒药物和疫苗来控制RSV疾病。

DESCRIPTION (provided by applicant): Respiratory syncytial virus (RSV) is the most important cause of respiratory infection in infants and is a significant cause of disease in immunocompromised patients and the elderly. In addition, RSV is closely related to other highly pathogenic viruses, such as Ebola and Nipah, and is a good model for studying their molecular biology. RSV has an RNA genome that is transcribed and replicated by the virus polymerase to produce mRNA and progeny genomes. The focus of this project is the characterization of the interaction of the RSV polymerase complex with its promoter in the RSV genome. This will be achieved by addressing three major aims. (1) The region of the RSV polymerase that interacts with its binding site in the promoter will be identified using surface residue modification and UV cross-linking techniques. Identification of the interacting site will be confirmed by reverse-genetics, using a minigenome assay that allows analysis of RSV transcription and replication in an intracellular environment. (2) The mechanism of encapsidation initiation, necessary for the elongation stage of RNA replication will be examined. Mutations will be made in the encapsidation signal in the full-length clone of RSV and a forward-genetics approach will be applied to identify which virus protein, and which region within that protein, it might interact with. (3) Virus and cellular proteins that interact with the polymerase complex will be identified using immunoprecipitation of polymerase complexes, mass spectrometry, and Western blotting. The roles of associated cellular proteins during different stages of RSV RNA synthesis will be determined by inhibiting their expression and examining RSV RNA synthesis in the minigenome system and RSV infected cells. The effects of promoter mutations that are known to differentially modulate transcription and replication will be investigated to determine if they affect the composition of the polymerase complex that binds the promoter. This research will provide information regarding the composition and regulation of a protein-RNA complex that plays a key role in RSV multiplication. In the long-term, this work will allow detailed structural analysis of this complex to be performed, which could aid in design of inhibitors to control RSV infection, and could identify mutations that could be made in the virus genome to generate a live- attenuated RSV vaccine. PUBLIC HEALTH RELEVANCE: Respiratory syncytial virus (RSV) is a major human pathogen, responsible for significant numbers of pediatric hospitalizations and for seasonal disease in the elderly. The aim of this project is to progress our molecular understanding of a critical step in the virus multiplication cycle, with the long-term goal of developing antiviral drugs and vaccines to control RSV disease.